![]() |
市场调查报告书
商品编码
1747101
日本血糖监测设备市场规模、份额、趋势及预测(按类型、检测地点、应用、最终用户和地区),2025 年至 2033 年Japan Blood Glucose Monitoring Devices Market Size, Share, Trends and Forecast by Type, Testing Site, Application, End User and Region, 2025-2033 |
2024年,日本血糖监测设备市场规模达9.3925亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到20.9104亿美元,2025-2033年期间的复合年增长率(CAGR)为8.60%。由于糖尿病盛行率上升、穿戴式装置技术进步以及医疗保健意识的提高,日本血糖监测设备市场正在蓬勃发展。此外,政府推动医疗保健普及的措施以及对家用监测解决方案的需求不断增长,也是市场成长的主要因素。
对创新监控解决方案的需求不断增长
近年来,受糖尿病管理和医疗保健意识增强的推动,日本血糖监测设备市场显着成长。尤其值得一提的是,由于生活方式改变、老化和遗传等因素,日本第2型糖尿病的发生率呈上升趋势,这导致对先进血糖仪和监测产品的需求不断增加。为此,各公司正开发更精准、更人性化、更便利的监测系统。持续血糖监测系统正在取代传统的血糖仪,该系统能够提供即时资料和全天血糖水平的详细洞察。这些设备可帮助患者和医疗保健提供者及时决定胰岛素剂量、饮食和运动,从而改善整体糖尿病护理。例如,雅培和德康医疗已在日本推出先进的持续血糖监测 (CGM) 技术,为使用者提供持续资料,以协助他们管理血糖值。雅培的 FreeStyle Libre 系统尤其受欢迎,它使用贴在皮肤上的小型感测器来追踪血糖水平。这些设备减少了频繁进行指尖采血测试的需求,并帮助患者积极管理糖尿病。预计向持续且便捷的监测解决方案的转变将继续推动市场创新和竞争。
政府对糖尿病照护进步的支持
血糖监测设备市场受惠于日本政府积极推动改善糖尿病照护。由于人口老化和糖尿病发生率上升,日本医疗保健系统更加重视改善疾病预防、早期识别和实用管理。同时,国家健康计画现已涵盖尖端血糖监测技术。此外,日本国民健康保险计划涵盖多种糖尿病管理设备,包括血糖仪和动态血糖监测 (CGM),使患者能够更轻鬆地以可负担的价格获得这些必要的设备。顺应这些趋势,政府计画正在增加对旨在对抗该国糖尿病流行的血糖监测设备的需求。例如,日本厚生劳动省一直在推动提高意识的活动,并资助改善糖尿病管理实践的研究。鼓励采用数据共享平台、血糖监测应用程式和远端患者监控等技术,也致力于将数位健康解决方案整合到日本的医疗保健系统中。因此,这些趋势有助于支撑日本血糖监测市场的持续成长,这对医护人员和患者都有利。同时,这些规定也有利于这些患者获得实施有效糖尿病治疗所需的资源,为医疗领域提供先进的设备。
市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。
The Japan blood glucose monitoring devices market size reached USD 939.25 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,091.04 Million by 2033, exhibiting a growth rate (CAGR) of 8.60% during 2025-2033. The Japan blood glucose monitoring devices market is growing due to rising diabetes prevalence, technological advancements in wearable devices, and increasing healthcare awareness. Additionally, government initiatives promoting healthcare access and rising demand for home-based monitoring solutions are primary factors of market growth.
Rising Demand for Innovative Monitoring Solutions
The Japanese market for blood glucose monitoring devices has grown significantly in recent years, driven by increased awareness of diabetes management and healthcare. Type 2 diabetes, in particular, is on the rise in Japan due to factors like lifestyle changes, aging, and genetics, leading to higher demand for advanced glucose meters and monitoring products. In response, companies are developing more precise, user-friendly, and personalized monitoring systems. Traditional glucose meters are being supplemented by continuous glucose monitoring systems, which provide real-time data and detailed insights into glucose levels throughout the day. These devices assist patients and healthcare providers in making timely decisions about insulin dosage, diet, and exercise, improving overall diabetes care. For example, Abbott and Dexcom have introduced advanced CGM technologies in Japan, offering users continuous data to help manage their glucose levels. Abbott's FreeStyle Libre system, which uses a small sensor applied to the skin to track glucose levels, is particularly popular. These devices reduce the need for frequent finger-prick tests and help patients actively manage their diabetes. The shift toward continuous and accessible monitoring solutions is expected to continue driving innovation and competition in the market.
Government Support for Diabetes Care Advancements
The market for blood glucose monitoring devices has benefited from the government of Japan's active promotion of better diabetes care. The Japanese healthcare system is putting more focus on improving disease prevention, earlier identification, and practical management as a result of an aging population and an increase in diabetes incidence. Along with this, national health initiatives now include leading-edge glucose monitoring technologies. In addition, several types of diabetes management devices, including glucose meters and CGMs, are included under Japan's National Health Insurance plan, making it easier for patients to receive these necessary devices at an affordable cost. In line with these trends, government programs are heightening the demand for blood glucose monitoring devices designed to fight the country's diabetes epidemic. For example, the Japanese Ministry of Health, Labour, and Welfare has been promoting awareness campaigns and research funding on improved diabetes management practices. Encouraging the adoption of technology such as data-sharing platforms, glucose monitoring apps, and remote patient monitoring also focused on integrating digital health solutions into Japan's healthcare system. As such, these trends serve to underpin continued growth within the Japanese market for blood glucose monitoring, which is beneficial to both healthcare professionals and patients. Simultaneously, such regulations serve to ease access to resources that these patients need to administer effective diabetes therapy to make available advanced equipment for the medical field.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.